Annexon Biosciences (ANNX) PT Lowered to $14 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts ANNX Hot Sheet
Price: $5.13 --0%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 22
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Annexon Biosciences (NASDAQ: ANNX) to $14.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Alto Neuroscience (ANRO) PT Raised to $55 at H.C. Wainwright
- Aurizon Holdings (AZJ:AU) (QRNNF) PT Lowered to AUD3.75 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
